Humana Inc.
Humana Reports Fourth Quarter 2023 Financial Results and Initial 2024 Guidance
Summary
Humana Inc. reported a GAAP loss per share of $4.42 for the fourth quarter of 2023 and provided initial guidance for 2024, anticipating a GAAP EPS of approximately $14.87 and an Adjusted EPS of approximately $16.00. The results reflect increased Medicare Advantage medical cost trends. Humana also announced an anticipated 100,000 increase in individual Medicare Advantage membership for 2024. Press releases and management remarks were posted on the Investor Relations page.
Profitelligence Alerts
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Exhibits (3)
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement